2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)


Por: Zamorano, JL, Munoz, D, Aboyans, V, Asteggiano, R, Galderisi, M, Habib, G, Lenihan, DJ, Lip, GYH, Lyon, AR, Fernandez, TL, Mohty, D, Piepoli, MF, Tamargo, J, Torbicki, A, Suter, TM, Achenbach, S, Agewall, S, Badimon, L, Baron-Esquivias, G, Baumgartner, H, Bax, JJ, Bueno, H, Carerj, S, Dean, V, Gaemperli, O, Kirchhof, P, Kolh, P, Lancellotti, P, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Carneiro, AV, Windecker, S, Minotti, G, Cardinale, D, de Azambuja, E, Dent, S, Erol, C, Ewer, MS, Farmakis, D, Fietkau, R, Fitzsimons, D, McGale, P, Ringwald, J

Publicada: 1 ene 2017
Resumen:


Filiaciones:
Badimon, L:
 Institut dInvestigació Biomèdica Sant Pau IIB Sant Pau, Barceona, Spain

Lancellotti, P:
 Centre Hospitalier Universitaire de Liege, Liege, Belgium
ISSN: 13889842
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Países Bajos
Tipo de documento: Article
Volumen: 19 Número: 1
Páginas: 9-42
WOS Id: 000393916000002
ID de PubMed: 27565769
imagen Green Published

MÉTRICAS